Sana Biotechnology (SANA) News Today $1.65 +0.05 (+3.13%) (As of 12/20/2024 05:23 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Sana Biotechnology (SANA) Receives a Buy from Morgan StanleyDecember 5, 2024 | markets.businessinsider.comSana: Major Inflection Point For SC291 In 2025 Targeting LupusDecember 4, 2024 | seekingalpha.comFmr LLC Has $131.49 Million Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA)Fmr LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 16.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,609,175 shares of the company's stock after purchasing aDecember 4, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANADecember 3, 2024 | prnewswire.comSana Biotechnology announces Fast Track designation for SC291December 3, 2024 | markets.businessinsider.comSana Biotechnology Gets FDA Fast Track Designation for SC291 Cell TherapyDecember 2, 2024 | marketwatch.comSana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus ErythematosusDecember 2, 2024 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Trading 9.8% Higher - Should You Buy?Sana Biotechnology (NASDAQ:SANA) Stock Price Up 9.8% - Should You Buy?November 29, 2024 | marketbeat.comSana Biotechnology Receives Buy Rating Amid Strategic Growth Opportunities and Advancements in Allogeneic CAR-T TherapiesNovember 27, 2024 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $8.00 price target on shares of Sana Biotechnology in a research report on Wednesday.November 27, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANANovember 25, 2024 | prnewswire.comSana Biotechnology to Present at December 2024 Investor ConferencesNovember 25, 2024 | globenewswire.comSana Biotechnology: The Story Becomes MurkierNovember 19, 2024 | seekingalpha.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANANovember 18, 2024 | prnewswire.comSana Biotechnology (NASDAQ:SANA) Reaches New 1-Year Low - Here's WhySana Biotechnology (NASDAQ:SANA) Hits New 12-Month Low - Time to Sell?November 18, 2024 | marketbeat.comDid Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- SANANovember 15, 2024 | stockhouse.comBaillie Gifford & Co. Sells 293,116 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Baillie Gifford & Co. lessened its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 2.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,278,084 shares of the company's stock after selling 293,116 shares dNovember 13, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Hits New 1-Year Low - What's Next?Sana Biotechnology (NASDAQ:SANA) Sets New 1-Year Low - Here's What HappenedNovember 11, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Sana Biotechnology (NASDAQ:SANA)HC Wainwright reaffirmed a "buy" rating and set a $8.00 price target on shares of Sana Biotechnology in a research note on Monday.November 11, 2024 | marketbeat.comBalanced Hold Rating on Sana Biotechnology Amid Delayed Program Timelines and Financial ChallengesNovember 11, 2024 | markets.businessinsider.comSana Biotechnology, Inc. Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comOptimistic Buy Rating for Sana Biotechnology Amid Strategic Advancements and High Return PotentialNovember 8, 2024 | markets.businessinsider.comSana Biotechnology Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 8, 2024 | globenewswire.comHC Wainwright Issues Positive Forecast for SANA EarningsSana Biotechnology, Inc. (NASDAQ:SANA - Free Report) - Investment analysts at HC Wainwright lifted their Q3 2024 EPS estimates for shares of Sana Biotechnology in a note issued to investors on Tuesday, November 5th. HC Wainwright analyst E. Bodnar now anticipates that the company will earn ($0.25November 7, 2024 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Sana Biotechnology (SANA)November 7, 2024 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Stock Quotes, Forecast and News SummaryNovember 6, 2024 | benzinga.comJMP Securities Downgrades Sana Biotechnology (SANA)November 6, 2024 | msn.comSana Biotechnology price target lowered to $8 from $11 at H.C. WainwrightNovember 6, 2024 | markets.businessinsider.comSana Biotechnology downgraded to Market Perform from Outperform at JMP SecuritiesNovember 5, 2024 | markets.businessinsider.comSana lowered to market perform by JMP over data uncertaintyNovember 5, 2024 | msn.comSana Biotechnology (NASDAQ:SANA) Sets New 12-Month Low After Analyst DowngradeSana Biotechnology (NASDAQ:SANA) Hits New 1-Year Low on Analyst DowngradeNovember 5, 2024 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Sana Biotechnology (NASDAQ:SANA) Stock PriceHC Wainwright lowered their price target on Sana Biotechnology from $11.00 to $8.00 and set a "buy" rating on the stock in a report on Tuesday.November 5, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Rating Lowered to "Market Perform" at JMP SecuritiesJMP Securities downgraded Sana Biotechnology from an "outperform" rating to a "market perform" rating in a research report on Tuesday.November 5, 2024 | marketbeat.comSana Biotechnology to focus on SC291, suspends SC291 in oncology and SC379November 5, 2024 | markets.businessinsider.comSana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025November 4, 2024 | globenewswire.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6% - Time to Sell?Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6% - What's Next?October 29, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Up 7.7% - Here's What HappenedSana Biotechnology (NASDAQ:SANA) Trading Up 7.7% - Here's What HappenedOctober 28, 2024 | marketbeat.comJ.P. Morgan Sticks to Their Hold Rating for Sana Biotechnology (SANA)October 22, 2024 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 6.4% - What's Next?Sana Biotechnology (NASDAQ:SANA) Shares Down 6.4% - Time to Sell?October 21, 2024 | marketbeat.comIs Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans?October 18, 2024 | finance.yahoo.comWhy Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to AnalystsOctober 16, 2024 | msn.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by Marshall Wace LLPMarshall Wace LLP decreased its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 78.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,713 shares of the company's stock after selOctober 8, 2024 | marketbeat.comA*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in SingaporeOctober 3, 2024 | finance.yahoo.comSana Biotechnology to Present at the Goldman Sachs Cell Therapy Day ConferenceSeptember 30, 2024 | globenewswire.comSana Biotechnology, Inc. (NASDAQ:SANA) Director Sells $612,000.00 in StockSeptember 27, 2024 | insidertrades.comMassachusetts Financial Services Co. MA Reduces Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA)Massachusetts Financial Services Co. MA reduced its position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 75.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 58,801 shares of the compSeptember 24, 2024 | marketbeat.comIntegral Health Asset Management LLC Increases Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA)Integral Health Asset Management LLC grew its holdings in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 22.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,200,000 shares of the companSeptember 23, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 4.1%Sana Biotechnology (NASDAQ:SANA) Stock Price Down 4.1%September 20, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Trading Up 9.6%Sana Biotechnology (NASDAQ:SANA) Trading Up 9.6%September 19, 2024 | marketbeat.comTD Asset Management Inc Has $2.21 Million Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA)TD Asset Management Inc reduced its position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 22.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 404,348 sharesSeptember 14, 2024 | marketbeat.com Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now SANA Media Mentions By Week SANA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SANA News Sentiment▼0.000.61▲Average Medical News Sentiment SANA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SANA Articles This Week▼03▲SANA Articles Average Week Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EVO News Today ARQT News Today NRIX News Today RCUS News Today KNSA News Today IMCR News Today OCUL News Today MESO News Today TVTX News Today NTLA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SANA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sana Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SANA Stock Alerts